Ibuprofen, the non-steroidal anti-inflammatory drug (NSAID) is safe and does not lead to higher rates of death or severe disease in patients hospitalized with COVID-19.
Ibuprofen, the non-steroidal anti-inflammatory drug (NSAID) is safe and does not lead to higher rates of death or severe disease in patients hospitalized with COVID-19. NSAIDs are common treatments for acute pain and rheumatological diseases such as rheumatoid arthritis and osteoarthrosis.
‘Around a third of patients (30.4 per cent) who had taken NSAIDs prior to hospital admission for Covid-19 died, a rate which was similar (31.3 per cent) in patients who had not taken NSAIDs. In patients with rheumatological disease, the use of NSAIDs did not increase mortality.’
Early in the pandemic, there was debate on whether the use of such drugs increased the severity of Covid-19, which led to urgent calls for investigations between NSAIDs and Covid-19. But, the study, led by ISARIC CCP-UK (International Severe Acute Respiratory and emerging Infection Consortium Clinical Characterisation Protocol United Kingdom), provides clear evidence that the continued use of NSAIDs in patients with Covid-19 is safe.
The findings are published in The Lancet Rheumatology journal.
Further, those who took NSAIDs were not more likely to be admitted to critical care, need invasive or non-invasive ventilation, or require oxygen, the researchers found.
"We now have clear evidence that NSAIDs are safe to use in patients with Covid-19, which should provide reassurance to both clinicians and patients that they can continue to be used in the same way as before the pandemic began," said lead author Ewen Harrison, from the University of Edinburgh.
Advertisement
Advertisement
Source-IANS